Free Trial

28,185 Shares in Ardent Health Partners, LLC (NYSE:ARDT) Purchased by Prudential Financial Inc.

Ardent Health Partners logo with Medical background
Remove Ads

Prudential Financial Inc. purchased a new position in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 28,185 shares of the company's stock, valued at approximately $481,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in ARDT. US Bancorp DE purchased a new stake in Ardent Health Partners in the fourth quarter worth approximately $31,000. Bank of New York Mellon Corp lifted its holdings in shares of Ardent Health Partners by 8.2% in the 4th quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company's stock worth $438,000 after acquiring an additional 1,941 shares during the last quarter. R Squared Ltd purchased a new stake in shares of Ardent Health Partners in the 4th quarter valued at $37,000. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners during the 3rd quarter valued at $42,000. Finally, New York State Common Retirement Fund purchased a new position in Ardent Health Partners in the 4th quarter worth $48,000.

Ardent Health Partners Price Performance

Shares of NYSE ARDT traded down $0.35 during midday trading on Friday, hitting $11.76. 244,757 shares of the company traded hands, compared to its average volume of 406,304. Ardent Health Partners, LLC has a 12-month low of $11.60 and a 12-month high of $20.72. The stock has a 50-day moving average price of $13.86 and a 200 day moving average price of $15.77. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Remove Ads

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion. On average, equities research analysts forecast that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ARDT. Stephens reaffirmed an "overweight" rating and set a $22.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Truist Financial reduced their price target on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Guggenheim started coverage on Ardent Health Partners in a research note on Wednesday. They issued a "buy" rating and a $16.00 price target on the stock. Morgan Stanley cut their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a report on Tuesday, January 21st. Finally, Mizuho decreased their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $20.58.

Check Out Our Latest Research Report on ARDT

About Ardent Health Partners

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Articles

Institutional Ownership by Quarter for Ardent Health Partners (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Partners Right Now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Pelosi Bets Big on AI: Her Top 5 Stock Picks

Pelosi Bets Big on AI: Her Top 5 Stock Picks

MarketBeat's Thomas Hughes breaks down Pelosi's stock picks, her strategy, and what these moves mean for the future of the AI industry.

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads